Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Promotions

Find ongoing promotions, complimentary technical guides and more.

Contact Us

Customer Service: +603-5631 0232

CRISPR

We are trusted worldwide for the latest, most innovative solutions in CRISPR/Cas9 products and services

Corporate Responsibility

Learn more about our commitment to people, green chemistry and the environment

About Us

Our life science business features a portfolio of more than 300,000 products enabling scientific discovery.

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

Darmstadt, Germany - October 19, 2020 Merck KGaA, Darmstadt, Germany Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer

Merck KGaA, Darmstadt, Germany today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.

Read More
Darmstadt, Germany - October 13, 2020 Merck KGaA, Darmstadt, Germany New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies

Merck KGaA, Darmstadt, Germany has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.

Read More
Darmstadt, Germany - October 12, 2020 Merck KGaA, Darmstadt, Germany Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA

Merck KGaA, Darmstadt, Germany today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.

Read More